The Rise of Medical Marijuana

The Rise of Medical Marijuana

Not surprisingly, this was another year when marijuana legalization spread like a weed. It is likely to continue in 2019 and many are expecting it to, eventually, be legalized throughout the US, like Canada and Uruguay. So far, 21 countries or territories have legalized cannabis fully or partially for medical and/or adult use. Its legalization in many states expanded as a result of the recent mid-term elections. CBD oil has become popular in 2020 for its many benefits. CBD can help with insomnia or sleep disorders, anxiety, depression, pain, inflammation, nausea and vomiting, according to Verified CBD.  

That means there are plenty of opportunities for physician and other medical ganjapreneurs to innovate, much like participating in various roles in the biopharma industry:

  1. Providing education and training to medical practitioners as edupreneurs
  2. Becoming cannabis science liaisons
  3. Doing basic drug discovery, development and testing, particularly since the passage of the recent Farm Bill
  4. Track and trace supply chain improvement
  5. Physician investing
  6. Retail distribution, sales and marketing
  7. Startup ganjapreneurship
  8. Regulatory affairs professionals
  9. Medical marijuana public health entrepreneurship and policy
  10. Product liability and expert witness participation
  11. Growth and extraction cannabis agrabusiness
  12. Digital health applications including e-metered dose inhaler applications and digital therapeutics
  13. Personalized pot practice

Here is the core course.

Many doctors are reluctant to recommend medical marijuana . Seize the opportunities. This bud's for you.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs

Share this article

Leave your comments

Post comment as a guest

0
terms and condition.
  • Lucy Thornton

    Weed is dangerous because if you smoke it for the first time you will realize that everything you were told to fear about it was a lie.

  • Stu Marland

    Marijuana > Alcohol

  • Kieran Owen

    Big Pharma won't be happy about this news

  • Andrew Norris

    I tried marijuana for the first time and did not like it. It made me suspicious, paranoid and generally anti-social. Then I tried it a second time (like any person who pursues logic would) to make sure it wasn't an isolated case. I liked it. It calmed my mind, made me ponder the philosophical depth of seemingly mundane things. Then I tried it again and it had a completely different effect. It made me super social.

  • Sam Thomson

    I'm 65 now and smoked marijuana for well over 50 years. Over that time period I have never moved up to a harder drug like alcohol or any other kind.

  • Matt Fuchs

    Hopefully more will follow and the secrets of this amazing plant will start to help the world the way it's supposed to.

Share this article

Arlen Meyers, MD, MBA

Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

   

Latest Articles

View all
  • Science
  • Technology
  • Companies
  • Environment
  • Global Economy
  • Finance
  • Politics
  • Society